As of 2026-04-01, the Intrinsic Value of Concentrix Corp (CNXC) is 128.85 USD. This CNXC valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 27.36 USD, the upside of Concentrix Corp is 370.90%.
The range of the Intrinsic Value is 58.69 - 357.89 USD
Based on its market price of 27.36 USD and our intrinsic valuation, Concentrix Corp (CNXC) is undervalued by 370.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (54.45) - (18.72) | (46.09) | -268.5% |
| DCF (Growth 10y) | 58.69 - 357.89 | 128.85 | 370.9% |
| DCF (EBITDA 5y) | (19.54) - 3.68 | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | 49.77 - 109.01 | 75.94 | 177.6% |
| Fair Value | -86.25 - -86.25 | -86.25 | -415.23% |
| P/E | (342.23) - (388.46) | (376.47) | -1476.0% |
| EV/EBITDA | 147.60 - 293.52 | 225.18 | 723.0% |
| EPV | 121.76 - 171.02 | 146.39 | 435.1% |
| DDM - Stable | (97.82) - (321.44) | (209.63) | -866.2% |
| DDM - Multi | 0.41 - 2.15 | 0.92 | -96.6% |
| Market Cap (mil) | 2,028.52 |
| Beta | 1.41 |
| Outstanding shares (mil) | 74.14 |
| Enterprise Value (mil) | 6,339.69 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.59% |
| Cost of Debt | 7.10% |
| WACC | 7.60% |